GOLDSTEIN JOSEPH L bought REGN
January 23, 2024 · Form 4 insider transaction
GOLDSTEIN JOSEPH L bought 2,707 shares of Regeneron Pharmaceuticals, Inc. at $625.60 per share, a transaction worth $1.69M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,707
Price
$625.60
Total value
$1.69M
InsiderGOLDSTEIN JOSEPH L
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 23, 2024
Filing dateJanuary 25, 2024
Shares owned after9,089
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023.